SAN DIEGO (AP) — SAN DIEGO (AP) — Kura Oncology Inc. (KURA) on Wednesday reported a loss of $19.2 million in its fourth quarter.
The San Diego-based company said it had a loss of 22 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.
The biopharmaceutical company posted revenue of $53.9 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $229.2 million.
For the year, the company reported a loss of $174 million, or $2.02 per share. Revenue was reported as $53.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KURA at https://www.zacks.com/ap/KURA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
